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ABSTRACT We describe a protein kinase, Shkl, from the
fission yeast Schizosaccharomyces pombe, which is structurally
related to the Saccharomyces cerevisiae Ste2O and mammalian
p65PAK protein kinases. We provide genetic evidence for
physical and functional interaction between Shkl and the
Cdc42 GTP-binding protein required for normal cell mor-
phology and mating in S. pombe. We further show that
expression of the STE20 gene complements the shki null
mutation and that Shkl is capable of signaling to the pher-
omone-responsive mitogen-activated protein kinase cascade
in S. cerevisiae. Our results lead us to propose that signaling
modules composed of small GTP-binding proteins and protein
kinases related to Shkl, Ste2O, and p65PAK, are highly con-
served in evolution and participate in both cytoskeletal func-
tions and mitogen-activated protein kinase signaling path-
ways.
ras genes are highly conserved in evolution and encode small
GTP-binding proteins that regulate cell growth and differen-
tiation in a broad spectrum of eukaryotic organisms (1). The
fission yeast Schizosaccharomyces pombe possesses a single
known ras homolog, rasl, the product of which is required for
at least two distinct cellular functions. First, Rasl is required
for sexual differentiation-namely, conjugation and sporula-
tion-which is induced by starvation and by peptide mating
pheromones that bind to serpentine receptors (2-4). Rasl
functions upstream of a mitogen-activated protein (MAP)
kinase (MAPK) module composed of the Byr2 [MAPK kinase
kinase (MAPKKK)], Byrl [MAPK kinase (MAPKK)], and
Spkl (MAPK) protein kinases (5). Data suggest that Rasl acts
in concert with a G protein a subunit homolog, Gpal, and that
both signal to the MAPK module (6). The yeast two-hybrid
system was used to show that Rasl physically associates with
the N-terminal regulatory domain of the Byr2 component of
the module (7). Numerous studies have demonstrated a role
for Ras proteins in the activation of MAPK cascades induced
by receptor tyrosine kinases in mammalian cells (for review,
see ref. 8). However, recent studies have suggested that Ras
proteins are also key elements of MAPK cascades induced by
certain mammalian heterotrimeric G protein-coupled serpen-
tine receptors (for review, see ref. 9), suggesting that signal-
transduction pathways analogous to the Ras-dependent pep-
tide mating factor response pathway of S. pombe are conserved
in evolution.
A second and distinct function of Rasl in S. pombe is the
control of cell morphology. Wild-type. S. pombe cells are
rod-like in morphology, whereas ras1nul1 mutants are spherical
in shape (2, 3). This aspect of Rasl function is separable from
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its functions on the MAPK module, as byrl, byr2, spkl, and
gpal null mutants are normal in morphology (10-13). We
recently reported that a member of the Rho subfamily of
Ras-related GTP-binding proteins, Cdc42 (14), acts down-
stream of Rasl in the regulation of morphology in S. pombe,
and that Rasl and Cdc42 form a multiprotein complex with
two other proteins, Scdl and Scd2 (15). Interestingly, Ras
proteins also participate in the morphologic transformation of
mammalian cells. Stimulation of mammalian cells with growth
factors or with oncogenic Ras proteins rapidly induces actin
reorganization and membrane ruffling (for review, see ref. 16).
As for S. pombe, Ras-dependent cytoskeletal control in mam-
malian cells is regulated by small GTP-binding proteins be-
longing to the Rho subfamily (17, 18).
In this report, we describe a protein kinase, Shk,1, and
provide evidence that it mediates functions of the Rasl/Cdc42
signaling complex in S. pombe. Shkl is highly related in
structure to the Ste2O kinase, which is required for sexual
response in Saccharomyces cerevisiae (19, 20), and to the
mammalian Cdc42/Racl-binding kinase, p65PAK (Pak) (21).
Our results lead us to propose that signaling pathways medi-
ated by small GTP-binding proteins and protein kinases
related to Shkl are conserved in evolution and participate in
regulation of the cytoskeleton and MAPK modules.
MATERIALS AND METHODS
Microbial Manipulation and Analysis. S. pombe strains SP870(h9O ade6-210 leul-32 ura4-D18) and SP66 (h9o ade6-216 leul-32)
were provided by D. Beach (Cold Spring Harbor Laboratory).
SP870D (h90 ade6-210/ade6-210 leul-32/leul-32 ura4-D18/ura4-
D18) is a spontaneous diploid derived from SP870 (V. Jung,
personal communication). SP206U (h90 ade6-210/ade6-210 leul-
32/leul-32 ura4-D18/ura4-D18 shk1::ura4/shk1) was con-
structed by transformation of SP870D with an Ec1136II-Msc I
fragment of shkl::ura4 from plasmid pBSSHK1::URA4.
SP206UA (h90 ade6-210/ade6-210 leul-32/leul-32 ura4-D18/
ura4-D18 shk1::ura4:.ADE2/shk1+) was constructed by trans-
forming SP206U with a Not I fragment of ura4:.ADE2 obtained
from pVIN (22). SP42N17 (h90 ade6-210 leul-32 ura4::adh1-
cdc42[T17N]-ADE2) was constructed by transforming the S.
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pombe strain SP66 with a Not I fragment of ura4::adhl-cdc42-
[Ti7N]-ADE2 from pVINCECDC42[T17N]. The S. cerevisiae
two-hybrid tester strain L40 (MATa ade2 his3 leu2 trpl
LYS2::1exA-HIS3 URA3::1exA-lacZ) has been described (23). S.
cerevisiae strains AN43-5A (MATa adel arg4 leu2-3, 112 trpl
ura3-52 mfal::FUS1::lacZ his3::FUS1::HIS3) and AN1016
(MATa leu2-3, 112 ura3-52 trpl his4 FUS1::lacZ::LEU2) were
from A. Neiman and I. Herskowitz (University of California, San
Francisco). S. pombe cultures were grown on either rich medium,
yeast extract/dextrose/adenine (YEA), or synthetic minimal
medium (PM) with appropriate auxotrophic supplements (3). S.
cerevisiae cultures were grown on either rich medium, yeast
extract/peptone/dextrose, or drop-out medium (DO) with auxo-
trophic supplements (24). Standard yeast genetic methods were
followed (24, 25).
Nucleic Acid Manipulation and Analysis. Plasmids pRD56,
pGADGH; pVJL11, pLBDCDC42SP, and pALUCDC42 have
been described (7, 15, 23, 26). The shkl gene was cloned from
a S. pombe genomic bank constructed in plasmid pWH5 (13,
27). pAAUCM is a ura4-based S. pombe-E. coli shuttle vector
used for expressing c-Myc epitope-tagged (28) proteins from
the strong S. pombe adhl promoter (S.M., unpublished work).
pARTlCM is similar to pAAUCM but contains the S. cerevi-
siae LEU2 gene as a selectable marker in place of ura4 (15).
pSL1508 is a YCpSO-based plasmid containing the hyperactive
stell[P279S] mutant gene (from B. Stevenson and G. Sprague,
University of Oregon). A BamHI-Kpn I fragment of the
STE20 gene was isolated from pSTE20-5 (from E. Leberer,
National Research Council, Montreal) and cloned into the
corresponding sites of pAAUCM. The resulting plasmid,
pAAUCMSTE20, expresses an N-terminal c-Myc epitope-
tagged protein lacking the first 69 amino acids of the Ste2O
regulatory domain. A Xho I-Ssp I fragment of the shkl open
reading frame was isolated from pSP206A and cloned into the
Xho I-EcoRV sites of pBluescriptlI SK (Stratagene). A Kpn
I-Sac I fragment of shkl was then isolated from the resulting
plasmid, pBSSHK1, and cloned into the corresponding sites of
pAAUCM, producing pAAUCMSHK1, and into pUC119, to
produce pUC119SHK1. A BamHI-EcoRI fragment of shkl
was isolated from pUC119SHK1 and cloned into the corre-
sponding sites of pGADGH to produce pGADSHK1. pGAD-
STE20 was constructed by cloning a BamHI-Sma I fragment
of the STE20 gene into the corresponding sites of pGADGH.
pRDSTE20RI, which was used for expression of a Ste2OAN
(residues 496-939) glutathione S-transferase (GST) fusion
protein in yeast, was provided by A. Neiman and I. Herskowitz.
pGSTSHKlAN was constructed by cloning an Xmn I-EcoRI
fragment of the shkl gene, from pBSSHK1, into pRD56, and
allows for expression of a ShklAN (residues 183-540) GST fusion
protein in S. cerevisiae. pLBDCDC42N17 was constructed by
cloning a BamHI-Xho I PCR-derived fragment of the dominant
negative cdc42[TJ7N] coding sequence into pVJL11. A Sal I-Sac
I fragment of cdc42[T17N] was isolated from pALUT17N (15)
and cloned into the corresponding sites of pVINCE1 (22) to
produce pVINCECDC42T17N. PCR was used to generate a
BamHI-Sac I deletion fragment of the shkl gene corresponding
to the putative Shkl regulatory domain (amino acid residues
1-262). This fragment was cloned into the corresponding sites of
pARTlCM to produce the plasmid pARTlCMSHKlAC. The
oligonucleotide primer pair 5'-AAGGATCCGAGCTCGACA-
CAATCCCAATGA and 5'-GTATTCCAAGATCTTCCA-
CAACTCTGATT were used to generate a 5' fragment of the
shkl sequence, and the primer pair 5'-ACCGTGAGATCTA-
AGCTTACAATATCCTTC and 5'-CGACGGTACCTTG-
GATGGCCATAGTAGCAA were used to generate a 3' frag-
ment of shkl. The 5' shkl PCR fragment was digested with Sac
I and Bgl II, and the 3' fragment was digested with Bgl II and KDn
I; then the two fragments were ligated together into a Sac I-Kpn
I fragment of pBluescriptII SK, producing pBSSHK1AKD. A
HindIIIfragment of the S. pombe ura4 gene was then cloned into
the corresponding site of the shkl fragment in pBSSHKlAKD.
The resulting plasmid, pBSSHK1::URA4, contains a ura4 re-
placement of the DNA sequence corresponding to amino acid
residues 337-391 of the Shkl kinase (see Fig. 1).
13-Galactosidase Assays. The filter assay for testing two-
hybrid interactions was done as described (7). LexA two-hybrid
experiments were conducted using LexA DNA-binding do-
main and Gal4-activating domain pairs of fusion proteins.
Liquid ,B-galactosidase assays were done as described (29).
Mating Assay. Mating assays were done as described (30).
Briefly, transformants were grown on PM agar for 6 days to
induce sexual activity. Zygotes, asci, and unmated cells within
individual clones were quantitated by microscopy.
RESULTS
Cloning and Sequence Analysis of shkl. A fragment of the
shkl coding sequence was cloned in a screen for STE20-related
genes from fission yeast and rat using the PCR with degenerate
oligonucleotide primers based on peptide sequences within
the S. cerevisiae Ste2O catalytic domain (MEYMEG/
HRDIKSDN). The PCR-derived fragment was used as a probe
to screen a S. pombe genomic library constructed in plasmid
pWH5 (27). Six strongly hybridizing transformants were iso-
lated from among -30,000 transformed bacterial colonies
screened. Plasmids were isolated from two of these transfor-
mants. pSP206A carried an insert of - 10.5 kb, whereas
pSP206B contained an insert -8 kb in size (data not shown).
Dideoxynucleotide chain-termination sequencing indicated
that pSP206A and pSP206B inserts each contained identical
STE20-related sequences, which we named shkl, for Ste2O
homologous kinase. The nucleotide sequence of shkl revealed
an intronless open reading frame of 1818 bp that encodes a
predicted protein of 540 amino acids. Shkl was most closely
related structurally to the S. cerevisiae Ste2O (49% identity)
(19, 20) and mammalian Pak (41% identity) (21) protein
kinases (Fig. 1). These kinases shared significant identity
within their catalytic domains (57% identity). In addition,
Shkl contains, in its putative regulatory domain, a peptide
motif similar in structure to the Cdc42/Racl-binding domain
of Pak (Fig. 1). A similar motif is found in the regulatory
domain of the S. cerevisiae Ste2O kinase (Fig. 1; ref. 21). Ste2O
and Shkl share additional regions of limited homology within
their regulatory domains not found in Pak.
Phenotype Conferred by Disruption ofshkl. A shkl disrup-
tion was made by replacing a fragment of shkl, encoding part
of the kinase domain, with ura4 (see Materials and Methods).
The shkl::ura4 DNA fragment was used to transform the
wild-type S. pombe diploid strain SP870D. Diploid transfor-
mants carrying a single disrupted copy of shkl were identified
by Southern blot analysis of genomic DNA digests. Two
independent shkl::ura4/shkl + diploids were sporulated, and
asci containing four spores were dissected. Spores were incu-
bated on rich medium for 4 days, and the resulting colonies
were replica-plated onto selective medium supplemented with
or not supplemented with uracil. A representative tetrad
analysis is shown in Fig. 2A. Of 46 tetrads analyzed, 40
produced two viable spores, whereas 6 produced only one
viable spore. None of the tetrads analyzed produced more than
two viable spores, and viable spores were never Ural. These
results demonstrate that the Shkl kinase is required for at least
one essential cellular function.
We examined further the shkl - phenotype by microscopic
analysis. Wild-type S. pombe cells are rod-like in morphology
(Fig. 2B). shkl- spores typically germinated but arrested as
spherical cells after one to several rounds of cell division (Fig.
2C). This phenotype is similar to that observed for S. pombe
strains carrying cdc42 null mutations (14). Because Shkl
contains a motif structurally similar to the Cdc42/Racl-
binding domain of the mammalian Pak protein kinase, we
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628 FIG. 1. Sequence alignments of S. pombe
275 Shkl, S. cerevisiae Ste2O, and mammalian Pak
354 protein kinases. Identical and similar amino acid
706 residues in the highly homologous catalytic do-
355 mains of these kinases are indicated by dark gray
433 boxes. Domains homologous to the Cdc42/Racl-
785 binding domain of Pak are highlighted by white
434 letters in the black box. Additional regions of
limited homology between the N-terminal puta-
785 tive regulatory domains of Shkl and Ste2O are
514 highlighted by outlined shaded boxes. The Shkl
and Pak sequences are complete, whereas resi-
89° dues 61-897 of the 939-residue Ste2O kinase are
544 shown.
examined whether Shkl and Cdc42 interact physically and
functionally.
Complex Formation Between Shkl and Cdc42. We used the
yeast two-hybrid system to determine whether Shkl and Cdc42
interact physically. Shkl was expressed as a Gal4-activating
domain fusion protein, and Cdc42 and Cdc42[T17N] were
expressed as fusions to the LexA DNA-binding domain. We
detected complex formation between Shkl and wild-type
Cdc42 but not between Shkl and the dominant negative
Cdc42[T17N] mutant protein. The T17N mutation is analo-
gous to mutations identified at the corresponding positions of
yeast and mammalian Ras proteins that result in defective
guanine nucleotide exchange (31-33). Our failure to detect an
interaction between Shkl and Cdc42[T17N] in the two-hybrid
system may indicate that interaction between the two proteins
is GTP-dependent and confirms the results of Manser et al
(21), who showed that binding between mammalian Cdc42 and
the mammalian Shkl homolog Pak is GTP-dependent. Like
Shkl, the structurally similar S. cerevisiae Ste2O kinase also
interacted with Cdc42 but not with Cdc42[T17N] (data not
shown). Neither Shkl nor Ste2O showed detectable interac-
tions with Rasl, Gpal, Byr2, Scdl, or Scd2 in the two-hybrid
system.
Functional Interaction Between Shkl, Cdc42, and Rasl in
S. pombe. Genetic experiments were conducted to establish a
functional relationship between Shkl and Cdc42. First, we
expressed the N-terminal putative regulatory domain of Shkl
(ShklAC) in wild-type S. pombe cells. Fig. 2D shows that
ShklAC caused cells to become spherical in morphology. This
phenotype was indistinguishable from that resulting from
overexpression of the dominant inhibitory Cdc42 mutant
protein Cdc42[T17N] (Fig. 2E) and further supports the notion
that the N-terminal domain of Shkl is regulatory in function.
Additional genetic evidence suggesting a functional interac-
tion between Cdc42 and Shkl came from overexpression of
Shkl in a S. pombe strain overexpressing Cdc42[T17N]. Cells
expressing this dominant inhibitory GTP-binding protein mate
at a frequency of about one-fiftieth that of wild-type cells.
Expression of Shkl partially suppressed this mating defect
(Table 1).
Cdc42 appears to act downstream of Rasl in S. pombe, and
data from two-hybrid experiments suggest that the two pro-
teins are part of a multiprotein complex (15). Unlike Cdc42,
Rasl is not required for cell viability, possibly because Cdc42
has sufficient basal activity to sustain cell viability in the
absence of Rasl. Although high-copy expression of Shkl failed
to measurably suppress the sporulation or conjugation defects
of a rasl null mutant, expression of the N-terminal regulatory
domain of Shkl markedly attenuated the hypersexual re-
sponses (elevated levels of agglutination and projection of
conjugation tubes) of a S. pombe strain carrying an activated
rasl[G17V] mutant gene (data not shown). These results are
consistent with a role for Shkl in the sexual functions of Rasl.
Further evidence for this comes from the functional homology
between Shkl and Ste2O, as described below.
Functional Homology Between Shkl and the S. cerevisiae
Ste2O Protein Kinase. To examine the functional relatedness
of Shkl and Ste2O, we constructed the high-copy plasmid
pAAUCMSTE20 for expressing Ste2O in S. pombe. A
shkl:.ADE2/shkl + diploid strain was transformed with
pAAUCMSTE20, and the resulting transformants were sub-jected to tetrad analysis. Expression of Ste2O restored not only
viability to shkl:.ADE2 haploid cells, as determined by the
recovery of ADE2+ spores, but also mating and normal
morphology (Fig. 2F). These results demonstrate that Shkl
and Ste2O are functionally related.
We also examined the function of Shkl in S. cerevisiae. In S.
cerevisiae, the Ste2O kinase is required for signaling from
heterotrimeric G protein-coupled peptide mating pheromone
receptors to a MAPK module composed of the Stell (MAP-
KKK), Ste7 (MAPKK), and Fus3/Kssl (MAPK) protein
kinases (19). Deletion of the Ste2O N-terminal regulatory
domain results in a kinase capable of constitutively activating
the mating factor response pathway in the absence of mating
pheromone (ref. 20; Table 2). Similarly, we found that high-
copy expression of a Shkl kinase lacking its N-terminal
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FIG. 2. Functional characterization of Shkl. (A) shkl is an essential
gene. The shkl +/shklD::ura4 diploid strain SP206U was grown on PM
medium to induce sporulation. Asci containing four spores were
dissected by micromanipulation, placed on YEA, and incubated for 4
days at 30°C. The resulting colonies were replica-plated onto PM
supplemented with (PM+Ura) or without (PM-Ura) uracil. No more
than two viable spores were isolated from any four-spore ascus, and no
viable spores were ever Ura+. (B) Photomicrograph of the wild-type
S. pombe strain SP870. (C) Photomicrograph of shkl- S. pombe cells
from culture of sporulated SP206U diploids. (D) Photomicrograph of
S. pombe cells transformed with plasmid pARTlCMSHKlAC, which
overexpresses the Shkl N-terminal regulatory domain. Note similarity
to cells in D. (E) Photomicrograph of S. pombe strain SP42N17, which
overexpresses the dominant inhibitory cdc42[TJ7N] gene. (F) Pho-
tomicrograph of shklnuil cells transformed with pAAUCMSTE20,
which expresses the S. cerevisiae STE20 gene. shklnull STE20+ cells are
viable, competent for mating, and normal in morphology. (X500.)
mating factor response pathway to a level nearly equal to that
induced by a Ste2O N-terminal deletion mutant (Table 2). Shkl
failed to induce FUS1-lacZ in a stell null mutant. These
results indicate that Shkl has a conserved ability to interact
with the S. cerevisiae mating factor-induced MAPK cascade.
Expression of the full-length Shkl sequence failed to provide
detectable suppression of the mating defect of a Ste2O deletion
mutant and only weakly restored FUS1 expression. We con-
clude from these experiments that Shkl is not properly regu-
lated when expressed in S. cerevisiae but that a constitutively
activated form of the kinase is fully capable of signaling to the
pheromone response cascade.
DISCUSSION
In S. cerevisiae, the Ste2O protein kinase is required for mating
pheromone-induced signal transduction (19, 20). Ste2O ap-
pears to function downstream from the mating pheromone
Table 1. Overexpression of shkl partially suppresses the mating
defect of a S. pombe strain expressing cdc42[T17N]
Strain Overexpressed gene* Mating,t %
SP66 None 53.3 ± 1.9
SP42N17 cdc42[T17N] 1.2 ± 0.2
cdc42[T17N], shkl 5.6 + 0.5
cdc42[TJ 7N], cdc42 10.1 ± 0.7
SP66 is a wild-type (cdc42+) S. pombe strain. SP42N17 is isogenic
to SP66 but carries an adhl-cdc42[T17N] sequence integrated at the
ura4 locus.
*Plasmids used for transformation of SP66 and SP42N17 were
pAAUCM (empty vector); pALUCDC42SP, for cdc42 overexpres-
sion; and pAAUCMSHK1, for shkl overexpression. pAAUCM con-
tains the adhl promoter sequence, which is also used for overexpres-
sion of cdc42[TJ7N], and its use as a control plasmid provides
assurance that the effects observed from shkl overexpression are not
the result of promoter competition.
tThe quantitative mating assay was done as described (30). Values
represent the average of three determinations.
receptor-coupled G protein and upstream of the pheromone-
responsive MAPK module (19). Establishing a similar role for
Shkl in S. pombe is complicated by the fact that shkl is an
essential gene. However, two results suggest a possible role for
Shkl in mating: (i) Shkl partially suppresses the mating defect
of a S. pombe strain expressing the dominant inhibitory
Cdc42[T17N] mutant protein; and (ii) expression of the Shkl
N-terminal putative regulatory domain attenuates the exag-
gerated sexual responses of a S. pombe strain carrying the
activated rasl[G17V] mutant gene.
Although it remains to be demonstrated conclusively, sev-
eral results lead us to speculate that Shkl may also participate
in the Rasl-regulated MAPK module. Shkl is capable of
signaling to the pheromone-responsive MAPK module in S.
cerevisiae (this report) and is also capable of inducing MAPK
activation in cell-free extracts ofXenopus laevis oocytes (S.M.
and T.P., unpublished work). Moreover, Ste2O, which also
signals to the MAPK module in S. cerevisiae, can functionally
replace Shkl in S. pombe. Interestingly, recent biochemical
studies by Wu and coworkersll and by A. Neiman and I.
Herskowitz (personal communication) indicate the Byr2 ho-
molog of S. cerevisiae, Stell, is a Ste2O substrate in vitro.
IlWu, C., Dignard, D., Whiteway, M., Thomas, D. Y. & Leberer, E.,
Yeast Genetics and Molecular Biology Meeting, Aug., 1994, Seattle,
abstr. no. 167A.




Overexpressed gene STEll + stell -
None 4.3 ± 1.4 0.6 ± 0.2
Ste2OAN 26.9 ± 3.3 0.8 ± 0.2
ShklAN 23.9 ± 6.8 1.0 ± 0.4
Stell[P279S] 8.8 ± 1.9 14.7 ± 1.1
Ste2OAN and ShklAN were expressed as GST fusion proteins from
the galactose-inducible GAL] promoter in plasmids pRDSTE20RI
and pRD56SHKlAN, respectively. Plasmid pSL1508 was used for
expression of the Stell[P279S] hyperactive mutant protein.
*The congenic STEJJ + and stell- strains used for this experiment
were AN43-5A and AN1016, respectively. Transformants were grown
in DO medium lacking uracil (DO-Ura) at 30°C to -5 x 106 cells per
ml, then transferred to DO-Ura-glucose containing 2% (wt/vol)
galactose, 2% (wt/vol) glycerol, and 1% ethanol, and incubated
overnight at 30°C. f3-Galactosidase activity was measured as de-
scribed (29). Units of f3-galactosidase were calculated as [1000 x
OD420]/[OD600 x time (min) x vol of cells (ml)]. Values represent
the averages of at least four determinations.
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As we have shown that Shkl and Cdc42 functionally interact
and that Rasl and Cdc42 functionally interact, we propose that
Rasl has two distinct inputs into the MAPK module: one by
direct physical interaction with Byr2 (7, 13) and the second
through Shkl, which Rasl regulates via Cdc42. Our results
have led us to propose the model depicted in Fig. 3, in which
the Rasl/Cdc42-regulated morphology control pathway in S.
pombe also participates in regulation of the Rasl-dependent
MAPK cascade, the Byr2 component of which interacts with
both Rasl and Shkl.
As in S. pombe, small GTP-binding proteins have been
implicated in morphological regulation in S. cerevisiae. A
homolog of Cdc42 is required for normal polarized cell growth
in S. cerevisiae, as is a Ras-related GTP-binding protein,
Rsrl/Budl (for review, see ref. 34). Although Ste2O has not as
yet been implicated in morphological control in S. cerevisiae, it
binds to Cdc42 (this study) and to a mammalian Rho-related
GTP-bitiding protein Racl (S.M. and L. Van Aelst, unpub-
lished work) and functionally replaces Shkl in S. pombe. These
results suggest a potential role for Ste2O and/or Ste2O-related
proteins in the morphological regulation of S. cereviside. In this
regard, a new gene, CLA4, encoding a protein kinase struc-
turally related to Ste2O, has recently been identified in S.
cerevisiae. Although deletion of either CLA4 or STE2O alone
does not affect cell viability, deletion of both genes is lethal,
suggesting that Cla4 and Ste2O perform overlapping, essential
cellular functions (35).
Whether Pak or related protein kinases play roles in mam-
malian cells analogous to the roles of their homologs in
yeast-namely, regulation of MAPK modules and cellular
morphology-remains to be seen.
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FIG. 3. Model for signal-transduction pathways mediated by Rasl
and Shkl in fission yeast. The Rasl protein regulates two genetically
separable signaling pathways in S. pombe, one involved in regulation
of a MAPK module composed of the Byr2, Byrl, and Spkl protein
kinases and the other involved in cytoskeletal control (see text for
details). Genetic and biochemical data suggest that Cdc42 and its
putative exchange factor Scdl function downstream of Rasl to mod-
ulate cytoskeletal regulation and that all three proteins are compo-
nents of a multiprotein complex that also contains Scd2, a protein that
has two SH3 domains (15). Genetic data presented in this report
suggest that Shkl links the Rasl/Cdc42 complex to control of the
cytoskeleton in S. pombe. We propose that Shkl may act on Byr2
because the S. cerevisiae Shkl homolog Ste2O phosphorylates Stell,
the S. cerevisiae homolog of Byr2, and S.pombe Shkl and S. cerevisiae
Ste2O are functionally homologous when expressed in the respective
hosts.
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